Journal of Clinical Epidemiology
Volume 53, Issue 2 , Pages 163-166 , February 2000

Incorporating patient preferences into randomized trials

  • Mark F Lambert

      Affiliations

    • Department of Health Sciences and Clinical Evaluation, University of York, York YO1 5DD, UK
    • Corresponding Author InformationCorresponding author. Gateshead & South Tyneside Health Authority, Ingham House, Horsley Hill Rd., South Shields NE33 3BN, UK. Tel.: +44 (0) 191 401 4500; fax: +44 (0) 191 401 4560.
    • ,
  • John Wood

      Affiliations

    • Department of Health Sciences and Clinical Evaluation, University of York, York YO1 5DD, UK

Received 1 August 1998 ,Revised 19 May 1999 ,Accepted 16 June 1999.

References 

  1. Schwartz D, Lellouche J. Explanatory and pragmatic attitudes in therapeutic trials. J Chron Dis. 1967;20:637–648
  2. Nelder J. New kinds of systematic design for spacing experiments. Biometrics. 1962;18:283–307
  3. Schulz KF. Subverting randomization in controlled trials. JAMA. 1995;274(18):1456–1458
  4. Brewin C, Bradley C. Patient preferences and randomised clinical trials. BMJ. 1989;299:313–315
  5. Zelen M. Strategy and alternate randomized designs in cancer clinical trials. Cancer Treat Rep. 1982;66:1095–1100
  6. Altman D. Statistics and ethics in medical research III–how large a sample?. BMJ. 1980;281:1336–1338
  7. Torgerson DJ, Klaber-Moffett J, Russell IT. Patient preferences in randomised trials (threat or opportunity?). J Health Serv Res Policy. 1996;1:194–197
  8. Cooper K, Grant A, Garratt A. The impact of using a partially randomised patient preference design when evaluating alternative managements for heavy menstrual bleeding. Br J Obstet Gynaecol. 1997;104:1367–1373

PII: S0895-4356(99)00146-8

Journal of Clinical Epidemiology
Volume 53, Issue 2 , Pages 163-166 , February 2000

Article Tools